| Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
| Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
| Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[11] Permethrin 5% lotion:Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix crème rinse (1% permethrin) for the treatment of head lice. PediatrDermatol. 2004 Nov-Dec;21(6):670-4. http://www.ncbi.nlm.nih.gov/pubmed/15575855
Permethrin 5% lotion:Frankowski BL, Bocchini Jr. JA and Council on School Health and Committee on Infectious Diseases. Head lice.Pediatrics2010;126:392-403. http://www.ncbi.nlm.nih.gov/pubmed/20660553
Permethrin 5% lotion:MarkLebwohl, Lily Clark and Jacob Levitt. Therapy for Head Lice Based on Life Cycle, Resistance, and Safety Considerations. Pediatrics2007;119(5):965-974. http://www.ncbi.nlm.nih.gov/pubmed/17473098
Permethrin 5% lotion:Nova Scotia District health authority public health services and the department of health promotion and protection. Guidelines for treatment of pediculosiscapitis (head lice). August 2008. [Online 2008][Cited 2013] Available at: https://novascotia.ca/dhw/publications/Public-Health-Education/Head_Lice_Guidelines_for_Treatment.pdf
Permethrin 5% lotion: Roberts RJ. Head lice. N Engl J Med 2002;346(21):1645-1650. https://www.ncbi.nlm.nih.gov/pubmed/12023998
Permethrin 5% lotion: MCC registered package insert for Skabi-rid®.
Permethrin 5% lotion: Diamantis SA, Morrell DS, Burkhart CN.Treatment of head lice. Dermatologic Therapy 2009;22:273–278. http://www.ncbi.nlm.nih.gov/pubmed/19580574
Permethrin 5% lotion: Jones KN, English III JC. Review of Common Therapeutic Options in the United States for the Treatment of Pediculosis Capitis.Clinical Infectious Diseases 2003; 36:1355–61. http://www.ncbi.nlm.nih.gov/pubmed/12766828
Permethrin 5% lotion: Madke B, Khopkar U. Pediculosis capitis: An update. Indian J Dermatol Venereol Leprol 2012;78:429-38. http://www.ncbi.nlm.nih.gov/pubmed/22772612
Permethrin 5% lotion: British National Formulary for children 2016-2017. (2016). 1st ed. London: BMJ Group, Pharmaceutical Press and RCPCH Publications Ltd.